Regeneron Pharmaceuticals, Inc.
NUCLEIC ACID CONSTRUCTS AND METHODS OF USE
Last updated:
Abstract:
The present disclosure provides bidirectional nucleic acid constructs that allow enhanced insertion and expression of a nucleic acid sequence of interest, e.g., encoding a therapeutic agent such as a polypeptide.
Status:
Application
Type:
Utility
Filling date:
16 Apr 2021
Issue date:
14 Oct 2021